Cancer News and Research

Latest Cancer News and Research

FDA approves Cimzia (certolizumab pegol) for active psoriatic arthritis

UCB announced today that the U.S. Food and Drug Administration has approved Cimzia (certolizumab pegol) for the treatment of adult patients with active psoriatic arthritis.

30 Sep 2013

Research roundup: Managed care for dementia patients; bundled payments after the hospital; disparities among Medicare beneficiaries

Dementia is a leading cause of death in the United States; however, patients dying with this disease may not receive optimal end-of-life care. ... many of these [nursing home] residents commonly experience burdensome and costly interventions, such as hospital transfers, tube-feeding, and intravenous antibiotics. ... Nursing home reimbursement policies are among the factors that incentivize more aggressive care. ... This study linked unique prospective clinical data with Medicare claims to describe and compare patterns of care between nursing home residents with advanced dementia enrolled in a Medicare managed-care insurance plan and those with fee-for-service Medicare.

30 Sep 2013

Men with prostate cancer experience more harm than good from routine PSA screening

Prostate cancer screening using the prostate-specific antigen test is widely used in France despite a lack of evidence showing that it reduces cancer deaths. Now, researchers have shown that men experience more harm than good from routine PSA screening, according to research to be presented today (Monday) by Professor Mathieu Boniol, at the 2013 European Cancer Congress.

30 Sep 2013

Viewpoints: Gerson says no compromises make for 'bad politics;' Democrats are getting a pass; Manchin signals a break in Democratic ranks

We are seeing that an anti-compromise ideology can make for bad politics. In our system, Obamacare will not be overturned by one house of Congress. A tea-party shutdown strategy - if implemented - would make securing the other house and the presidency less likely for Republicans. And the political energy consumed by Cruz and crew has not been available to promote incremental limits on Obamacare that might have aided GOP political prospects (Michael Gerson, 9/26).

30 Sep 2013

Biology of tumour more important than primary site, say researchers

Identifying the molecular profile of a tumour where the primary site is unknown is crucial to the choice of treatment, the 2013 European Cancer Congress, will hear on Monday.

30 Sep 2013

Scientists discover two new compounds that could help treat CF patients having common mutation

Cystic fibrosis is a lethal genetic disorder that in France affects one child per 4,500 births. An international team led by scientists at the Institut Fédératif de Recherche Necker-Enfants Malades (CNRS/Inserm/Université Paris Descartes), led by Aleksander Edelman, has recently discovered two new compounds that could be used to treat patients carrying the most common mutation.

30 Sep 2013

Study suggests relationship between smoking history, response to inhibiting PD-L1/PD-1 pathway

New results from a trial of an antibody that helps the immune system to recognise and attack cancer cells have shown particularly encouraging responses in patients who are smokers or former smokers.

30 Sep 2013

GW SPHHS awarded three grants to research on critical public health problems

The George Washington University School of Public Health and Health Services has been awarded three large grants for projects that will look for innovative solutions to some of the nation's most pressing public health challenges.

30 Sep 2013

AMGEN announces additional results from talimogene laherparepvec Phase 3 trial

AMGEN today announced additional results from a pivotal Phase 3 trial evaluating talimogene laherparepvec in patients with unresected stage IIIB, IIIC or IV melanoma compared to granulocyte-macrophage colony-stimulating factor (GM-CSF).

30 Sep 2013

Discoveries pave way for use of new therapies for advanced thyroid cancer

For many years, patients with advanced thyroid cancer faced bleak prospects and no viable treatment options. But now, building on recent discoveries about the genetics and cell signaling pathways of thyroid tumors, researchers are developing exciting new weapons against the disease, using kinase inhibitors that target tumor cell division and blood vessels.

30 Sep 2013

Chinese and Western medicine combination could offer new hope for cancer treatments, therapies

Combining traditional forms of Chinese and Western medicine could offer new hope for developing new treatments for liver, lung, colorectal cancers and osteosarcoma of the bones.

30 Sep 2013

Health expenditure link to cancer survival in Europe

The more an EU national government spends on health, the fewer the deaths after a cancer diagnosis in that country, according to new research to be presented to the 2013 European Cancer Congress today (Sunday) and published simultaneously in the leading cancer journal Annals of Oncology.

30 Sep 2013

Department of Defense backs tissue-engineering research for soldiers, civilians

A $75 million Department of Defense grant to improve technologies to treat soldiers injured on the battlefield and advance care for the public will involve bioengineers at Rice University and the University of Texas Health Science Center at Houston.

30 Sep 2013

Diabetic patients at greater risk of breast, colon cancer

Diabetes is linked to an increased risk of developing cancer, and now researchers have performed a unique meta-analysis that excludes all other causes of death and found that diabetic patients not only have an increased risk of developing breast and colon cancer but an even higher risk of dying from them.

30 Sep 2013

Colorectal cancer in younger people appears to be more aggressive

Younger patients with colorectal cancer that has spread (metastasised) to other parts of the body represent a high-risk group that is less likely to respond to anti-cancer treatments.

29 Sep 2013

First Phase II study: Everolimus drug slows spread of advanced papillary kidney cancer

The first Phase II study to investigate the use of the anti-cancer drug, everolimus, for the initial treatment of advanced papillary kidney cancer has shown that it is successful in slowing or preventing the spread of the disease, according to research to be presented today (Sunday) at the 2013 European Cancer Congress.

29 Sep 2013

Colorectal cancer screening in European countries highly effective in reducing mortality

Screening for colorectal cancer in European countries is highly effective in reducing mortality from the disease. Some of the resources currently being devoted to breast and prostate screening programmes, where the evidence of effectiveness is much less clear-cut, should be reallocated to the early detection of CRC, the 2013 European Cancer Congress will hear today (Sunday).

29 Sep 2013

Doing yoga during menopause linked to less insomnia

Taking a 12-week yoga class and practicing at home was linked to less insomnia-but not to fewer or less bothersome hot flashes or night sweats. The link between yoga and better sleep was the only statistically significant finding in this MsFLASH (Menopause Strategies: Finding Lasting Answers for Symptoms and Health) Network randomized controlled trial.

29 Sep 2013

Scientists identify 140 regions of genetic code believed to contain undiscovered cancer genes

Scanning the DNA of nearly 5,000 tumor samples, a team led by scientists at Dana-Farber Cancer Institute and the Broad Institute has identified 140 regions of scrambled genetic code believed to contain many undiscovered cancer genes.

29 Sep 2013

Americans in highest socio-economic groups have 13% greater chance of surviving SAH

Americans in the highest socio-economic groups have a 13 per cent greater chance of surviving a kind of stroke known as a subarachnoid hemorrhage than those in the lowest socio-economic groups, a new study has found.

29 Sep 2013

Cancer News and Research

Latest Cancer News and Research

FDA approves Cimzia (certolizumab pegol) for active psoriatic arthritis

Research roundup: Managed care for dementia patients; bundled payments after the hospital; disparities among Medicare beneficiaries

Men with prostate cancer experience more harm than good from routine PSA screening

Viewpoints: Gerson says no compromises make for 'bad politics;' Democrats are getting a pass; Manchin signals a break in Democratic ranks

Biology of tumour more important than primary site, say researchers

Scientists discover two new compounds that could help treat CF patients having common mutation

Study suggests relationship between smoking history, response to inhibiting PD-L1/PD-1 pathway

GW SPHHS awarded three grants to research on critical public health problems

AMGEN announces additional results from talimogene laherparepvec Phase 3 trial

Discoveries pave way for use of new therapies for advanced thyroid cancer

Chinese and Western medicine combination could offer new hope for cancer treatments, therapies

Health expenditure link to cancer survival in Europe

Department of Defense backs tissue-engineering research for soldiers, civilians

Diabetic patients at greater risk of breast, colon cancer

Colorectal cancer in younger people appears to be more aggressive

First Phase II study: Everolimus drug slows spread of advanced papillary kidney cancer

Colorectal cancer screening in European countries highly effective in reducing mortality

Doing yoga during menopause linked to less insomnia

Scientists identify 140 regions of genetic code believed to contain undiscovered cancer genes

Americans in highest socio-economic groups have 13% greater chance of surviving SAH

Industry Focus eBook - Oncology (1st Edition) eBook

How Pulp Fixin Is Turning Paper into High-Performance Sustainable Labware

A new method to measure intracellular water in biological systems

Obesity, GLP-1s, and metabolic care

Cancer News and Research

Latest Cancer News and Research

Industry Focus eBook - Oncology (1st Edition) eBook

How Pulp Fixin Is Turning Paper into High-Performance Sustainable Labware

A new method to measure intracellular water in biological systems

Obesity, GLP-1s, and metabolic care

Newsletters you may be interested in